相似文献
1
Fluorescence of nails and hair on Wood's lamp examination in Covid pandemic; undefined effect of Favipiravir in humans.
Dermatol Ther. 2021 Jan;34(1):e14740. doi: 10.1111/dth.14740. Epub 2021 Jan 11.
2
Luminescence of favipiravir in skin appendages and sclera. A controlled study and literature review.
Photodermatol Photoimmunol Photomed. 2024 Jan;40(1):e12919. doi: 10.1111/phpp.12919. Epub 2023 Oct 26.
3
Nail and hair findings developing in patients treated for COVID-19 infection fluorescence of keratinized tissues on Wood's lamp in COVID-19 disease.
J Cosmet Dermatol. 2022 May;21(5):1788-1795. doi: 10.1111/jocd.14855. Epub 2022 Feb 28.
4
Evaluation of the frequency and intensity of favipiravir-associated yellow-green fluorescence in lunulae, hair, and face.
J Cosmet Dermatol. 2022 Mar;21(3):1199-1207. doi: 10.1111/jocd.14189. Epub 2021 May 14.
5
Wood's lamp examination of hair and nails related to COVID-19 treatment.
Dermatol Ther. 2021 Nov;34(6):e15174. doi: 10.1111/dth.15174. Epub 2021 Nov 1.
6
Yellow-white fluorescence on the nails: A novel finding of Favipiravir used for the treatment of COVID-19.
J Cosmet Dermatol. 2021 Aug;20(8):2392-2393. doi: 10.1111/jocd.14214. Epub 2021 May 31.
7
Fluorescence in the Sclera, Nails, and Teeth Secondary to Favipiravir Use for COVID-19 Infections.
J Clin Aesthet Dermatol. 2022 Mar;15(3):35-37.
8
Molnupiravir-associated nail and hair fluorescence on Wood's lamp examination.
Clin Exp Dermatol. 2023 Mar 22;48(4):381-382. doi: 10.1093/ced/llac119.
9
Fingernail lunula luminescence in COVID-19 patients: Is it a favipiravir-related reaction or a novel manifestation of coronavirus infection.
Photodermatol Photoimmunol Photomed. 2021 Jul;37(4):343-344. doi: 10.1111/phpp.12660. Epub 2021 Feb 3.
10
Fluorescence of ocular surface in a Covid -19 patient after Favipiravir treatment: a case report.
Virol J. 2021 Jul 13;18(1):146. doi: 10.1186/s12985-021-01610-3.
引用本文的文献
1
Case report: Favipiravir-induced bluish corneal discoloration in infant with COVID-19.
Front Pediatr. 2023 Apr 19;11:1154814. doi: 10.3389/fped.2023.1154814. eCollection 2023.
2
Follow-up of Favipiravir-Induced Nail Fluorescence: Implications for Nail and Drugs.
Dermatol Pract Concept. 2023 Jan 1;13(1):e2023011. doi: 10.5826/dpc.1301a11.
3
Evaluation of In Vitro Distribution and Plasma Protein Binding of Selected Antiviral Drugs (Favipiravir, Molnupiravir and Imatinib) against SARS-CoV-2.
Int J Mol Sci. 2023 Feb 2;24(3):2849. doi: 10.3390/ijms24032849.
4
Nail Changes in COVID-19: A Cross Sectional Study From India.
Indian Dermatol Online J. 2022 May 5;13(3):326-333. doi: 10.4103/idoj.idoj_586_21. eCollection 2022 May-Jun.
5
Optical biometric measurements in patients with previous COVID-19 treatment.
Spektrum Augenheilkd. 2022 Jul 26:1-7. doi: 10.1007/s00717-022-00526-9.
6
The efficacy and adverse effects of favipiravir on patients with COVID-19: A systematic review and meta-analysis of published clinical trials and observational studies.
Int J Infect Dis. 2022 Jul;120:217-227. doi: 10.1016/j.ijid.2022.04.035. Epub 2022 Apr 22.
7
Dermatological Manifestations of COVID-19 in Children.
Indian Pediatr. 2022 May 15;59(5):393-399. doi: 10.1007/s13312-022-2521-6. Epub 2022 Mar 10.
8
Evaluation of Nail Findings in Patients with COVID-19 History and Wood's Lamp Examination.
Skin Appendage Disord. 2021 Oct 12;38(2):1-6. doi: 10.1159/000518983.
9
An unusual case of bluish discoloration of the cornea after favipiravir therapy for COVID-19.
Indian J Ophthalmol. 2021 Dec;69(12):3778-3779. doi: 10.4103/ijo.IJO_1023_21.
10
Wood's lamp examination of hair and nails related to COVID-19 treatment.
Dermatol Ther. 2021 Nov;34(6):e15174. doi: 10.1111/dth.15174. Epub 2021 Nov 1.
本文引用的文献
1
Experimental design approach for development of spectrofluorimetric method for determination of favipiravir; a potential therapeutic agent against COVID-19 virus: Application to spiked human plasma.
Spectrochim Acta A Mol Biomol Spectrosc. 2021 Mar 15;249:119241. doi: 10.1016/j.saa.2020.119241. Epub 2020 Nov 28.
2
An effective drug against COVID-19: reality or dream?
Expert Rev Respir Med. 2021 Apr;15(4):505-518. doi: 10.1080/17476348.2021.1854092. Epub 2020 Dec 6.
3
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity.
Proc Natl Acad Sci U S A. 2020 Oct 27;117(43):26955-26965. doi: 10.1073/pnas.2014441117. Epub 2020 Oct 9.
4
Tissue distributions of antiviral drugs affect their capabilities of reducing viral loads in COVID-19 treatment.
Eur J Pharmacol. 2020 Dec 15;889:173634. doi: 10.1016/j.ejphar.2020.173634. Epub 2020 Oct 6.
5
Review of adverse cutaneous reactions of pharmacologic interventions for COVID-19: A guide for the dermatologist.
J Am Acad Dermatol. 2020 Dec;83(6):1738-1748. doi: 10.1016/j.jaad.2020.08.006. Epub 2020 Aug 7.
6
Favipiravir, an antiviral for COVID-19?
J Antimicrob Chemother. 2020 Jul 1;75(7):2013-2014. doi: 10.1093/jac/dkaa171.
7
Yellow lunulae with fluorescence after tetracycline therapy.
Arch Dermatol. 1980 Apr;116(4):438-40.
Zotero 插件